|
|
Volumn 27, Issue 13, 2009, Pages 2114-2116
|
|
Vox populi: Using community-based studies to determine best management of early-stage nonseminoma
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BLEOMYCIN;
CISPLATIN;
ETOPOSIDE;
ANTINEOPLASTIC AGENT;
BEP PROTOCOL;
CANCER ADJUVANT THERAPY;
CANCER COMBINATION CHEMOTHERAPY;
CANCER MORTALITY;
CANCER RECURRENCE;
CANCER RELAPSE;
CANCER RESEARCH;
CANCER RISK;
CANCER STAGING;
CANCER SURGERY;
CANCER SURVIVAL;
CANCER THERAPY;
CLINICAL TRIAL;
COMMUNITY CARE;
DRUG FATALITY;
DRUG MEGADOSE;
EARLY CANCER;
EDITORIAL;
HAIR LOSS;
HEALTH CARE DELIVERY;
HEARING IMPAIRMENT;
HUMAN;
INFERTILITY;
KIDNEY FAILURE;
LYMPH NODE DISSECTION;
MALE;
METABOLIC SYNDROME X;
MULTIPLE CYCLE TREATMENT;
NEUTROPENIA;
NON SEMINOMATOUS GERMINOMA;
OUTCOME ASSESSMENT;
PATIENT COMPLIANCE;
POPULATION RESEARCH;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
SALVAGE THERAPY;
SECOND CANCER;
TREATMENT PLANNING;
VASCULAR DISEASE;
LYMPHADENECTOMY;
NEOPLASM;
NOTE;
TESTIS TUMOR;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BLEOMYCIN;
CISPLATIN;
ETOPOSIDE;
HUMANS;
LYMPH NODE EXCISION;
MALE;
NEOPLASM STAGING;
NEOPLASMS, GERM CELL AND EMBRYONAL;
TESTICULAR NEOPLASMS;
|
|
EID: 65549088972
PISSN: 0732183X
EISSN: None
Source Type: Journal
DOI: 10.1200/JCO.2008.21.1524 Document Type: Editorial |
|
Times cited : (14)
|
|
References (7)
|
